Predictive performance of Bayesian method in a simulation work: One-compartment open linear model containing an oral route.
スポンサーリンク
概要
- 論文の詳細を見る
The Bayesian weighted least-squares method (BWLS) was evaluated by simulationwork. One hundred simulated patients were created by random number generatorthrough a logarithm transformation. Theophylline was examined as a typical drugwhich obeys a one-compartment open linear model: total body clearance (CL), 0.04±0.02<I>l</I>/hr/kg; volume of distribution (V<SUB>d</SUB>), 0.50±0.09<I>l</I>/kg; rate constant of absorption (k<SUB>a</SUB>), 0.96±0.62hr<SUP>-1</SUP>. A non-uniform but periodic dosage regimen containing an oral route, designed to give a range of 10 to 20μg/ml of serum drug concentration (SDC) in thesteady-state period, was assumed.<BR>The BWLS with one SDC measurement provided time-dependent precision and biasin both CL and V<SUB>d</SUB> estimates; by increasing the time between the sampling and theonset of therapy, the precision in CL esimates increased but the precision in V<SUB>d</SUB> decreased, and BWLS etimated the CL and V<SUB>d</SUB> with a prediction error of approximately 10% and20% respectively, after 14 hr from the onset of therapy (mean half-life was 10.5 hr).The k<SUB>a</SUB> could be estimated inaccurately (>110% RMSE). In the predictions of steadystate SDCs, the precision and bias also showed the time-dependent profile as a functionof the sampling times and, moreover, the prediction times: 1.6 to 8.6μg/ml as a rootmean squared error (RMSE), -2.9 to 1.1μg/ml as a mean prediction error (ME).The utilization of two SDC measurements partly improved the predictive performance of BWLS for estimating CL and V<SUB>d</SUB>. From the simulation work it was concluded thatthe BWLS would provide reliable estimations of parameters such as CL and V<SUB>d</SUB>, andclinically acceptable predictions of the subsequent SDCs, given appropriate populationparameter values, means and variances, and sampling times, even when as few as oneor two SDC measurements are available.
- 一般社団法人 日本臨床薬理学会の論文
著者
-
Ieiri Ichiro
Department Of Clinical Pharmacokinetics Graduate School Of Pharmaceutical Sciences Kyushu University
-
Aoyama Toshinobu
Department Of Hospital Pharmacy Faculty Of Medicine Kyushu University
-
Higuchi Shun
Department Of Clinical Pharmacokinetics Division Of Pharmaceutical Sciences Kyushu University
-
IEIRI Ichiro
Department of Hospital Pharmacy, Faculty of Medicine, Kyushu University
関連論文
- Population pharmacokinetics of pranlukast hydrate dry syrup in children with bronchial asthma
- Sensitive and Real-Time Method for Evaluating Corneal Barrier Considering Tear Flow
- Polymorphism of MDR1 Gene in healthy Japanese Subjects : A Novel SNP with an Amino Acid Substitution (Glu108Lys)
- Population Pharmacokinetics of Pranlukast Hydrate Dry Syrup in Children with Allergic Rhinitis and Bronchial Asthma
- Population pharmacokinetics of pranlukast hydrate dry syrup in children with allergic rhinitis and bronchial asthma
- Statistical Evaluation of Clinical Trial Design for a Population Pharmacokinetic Study : A Case Study
- Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866)
- Clinical Management of Boric Acid Ingestion : Pharmacokinetic Assessment of Efficacy of Hemodialysis for Treatment of Acute Boric Acid Poisoning
- Role of Glucocorticoid Receptor in the Regulation of Cellular Sensitivity to Irinotecan Hydrochloride
- Dubin-Johnson 症候群患者に認めたABCC2遺伝子の部分欠損(exon 7 全域)例
- FORMATION OF HIGHLY ANALGESIC MORPHINE-6-GLUCURONIDE FOLLOWING PHYSIOLOGIC CONCENTRATION OF MORPHINE IN HUMAN BRAIN
- Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism
- Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
- Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy
- Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects
- Enantioselective determination of thiamylal in human serum by high-performance liquid chromatography
- The Effects of Genetic Polymorphisms of CYP2C9 and CYP2C19 on Phenytoin Metabolism in Japanese Adult Patients with Epilepsy : Studies in Stereoselective Hydroxylation and Population Pharmacokinetics
- The effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic side effects : In vivo and in vitro studies
- Drug interactions of zonisamide with phenytoin and sodium valproate: serum cncentrations and protein binding
- The Effect of Phenytoin Withdrawal on Valproic Acid Free Fraction : A Case Report
- Utility of a Rectal Suppository Containing the Antiepileptic Drug Zonisamide
- Chronotoxicity of Methotrexate in Mice and Its Relation to Circadian Rhythm of DNA Synthesis and Pharmacokinetics
- Clinical Utility of a New and Simple Technique for Individualizing Phenytoin Dosage
- Evaluation of Single-Point Phenytoin Dosage Prediction Methods in Pediatric Patients
- Predicting Serum Lithium Concentration Using Bayesian Method : A Comparison with Other Methods
- PEDA : A MICROCOMPUTER PROGRAM FOR PARAMETER ESTIMATION AND DOSAGE ADJUSTMENT IN CLINICAL PRACTICE
- Dosing Time-Dependency of the Arthritis-Inhibiting Effect of Tacrolimus in Mice
- Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure
- Predictive performance of Bayesian method in a simulation work: One-compartment open linear model containing an oral route.